The effects of levosimendan in patients undergoing transcatheter aortic valve replacement- a retrospective analysis
Background: Aortic stenosis (AS) increases left ventricular afterload, leading to cardiac damage and heart failure (HF). Transcatheter aortic valve replacement (TAVR) is an effective therapy for AS. No inotropic agents including levosimendan have been evaluated in patients undergoing TAVR.Methods: A...
Main Authors: | Zhenyan Zhao, Zhen Meng, Guangyuan Song, Chunrong Wang, Sheng Shi, Jie Zhao, Hongliang Zhang, Moyang Wang, Guannan Niu, Zheng Zhou, Jianhui Wang, Yongjian Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.969088/full |
Similar Items
-
Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study
by: Xiangming Hu, et al.
Published: (2024-02-01) -
Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve Study
by: S. Chris Malaisrie, MD, et al.
Published: (2022-11-01) -
Transcatheter, valve-in-valve transapical aortic and mitral valve implantation, in a high risk patient with aortic and mitral prosthetic valve stenoses
by: Harish Ramakrishna, et al.
Published: (2015-01-01) -
Determinants of device success after transcatheter aortic valve replacement in patients with type-0 bicuspid aortic stenosis
by: Zhicheng Xiao, et al.
Published: (2023-11-01) -
Use of levosimendan in acute and advanced heart failure: short review on available real-world data
by: Pashkovetsky E, et al.
Published: (2019-06-01)